ImmuneAbcellera and Vertex partner on TCEs for autoimmune diseasesAbcellera Biologics Inc. has established a collaboration with Vertex Pharmaceuticals Inc. to research, develop, manufacture and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions.